Bio-Rad Laboratories Inc Class A (BIO)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$301.71

Buy

$314.63

arrow-down$-5.84 (-1.86%)

Prices updated at 12 Dec 2025, 23:21 EST

Prices minimum 15 mins delay

Prices in USD

Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Norman Schwartz

CEO

Mr. Norman Schwartz

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

7,700

Head office

1000 Alfred Nobel Drive

Hercules

United States

94547

+1 510 724-7000

investor_relations@bio-rad.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Rajat Mehta Executive Vice President, Global Commercial Operations	-
Mr. Arnold A. Pinkston Independent Director	0.21m
Mr. Gregory K. Hinckley Lead Independent Director	0.24m
Mr. Jonathan P. DiVincenzo President and Chief Operating Officer	0.20m
Mr. Roop K. Lakkaraju Principal Accounting Officer, Executive Vice President and Chief Financial Officer	0.43m
Mr. Jeffrey L. Edwards Independent Director	0.23m
Mr. Norman Schwartz Chairman of the Board and Chief Executive Officer	1.06m
Ms. Melinda Litherland Independent Director	0.23m
Ms. Allison Schwartz Director and Vice President, Global Supply Chain Clinical Diagnostics Group Operations	-
Ms. Colleen Corey Executive Vice President, Global Human Resources	-
Mr. Sedat Evran Executive Vice President, Global Supply Chain	-
Mr. James J. Barry Executive Vice President and President, Life Science Group	-
Ms. Courtney Camp Enloe Executive Vice President, General Counsel and Secretary	-
Ms. Eva Anette Engelhardt Executive Vice President and President, Clinical Diagnostics Group	0.29m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Arnhold & S. Bleichroeder Advisers, LLC	2,520,319
First Eagle Investment Management, LLC	2,173,402
First Eagle Global Fund	1,878,739
Vanguard Group Inc	1,846,543
BlackRock Inc	1,695,849

Director dealings

Date chevron-l-regular chevron-r-regular	Action
24 Oct 2024	-
20 Oct 2024	-
20 Oct 2024	-
20 Oct 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-
06 Sep 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.